Daniel J. Mota

ORCID: 0000-0002-3415-2892
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Histone Deacetylase Inhibitors Research
  • Epigenetics and DNA Methylation
  • Malaria Research and Control
  • Ubiquitin and proteasome pathways
  • Protein Degradation and Inhibitors
  • HIV/AIDS drug development and treatment
  • Mosquito-borne diseases and control
  • Hepatitis Viruses Studies and Epidemiology
  • Cancer Research and Treatments
  • Computational Drug Discovery Methods
  • Global Maternal and Child Health
  • Graphene and Nanomaterials Applications
  • Nerve injury and regeneration
  • Telomeres, Telomerase, and Senescence
  • Genetics, Bioinformatics, and Biomedical Research
  • Biological Research and Disease Studies
  • Parasites and Host Interactions

University of California, San Francisco
2017-2018

City of Hope
2015-2018

Beckman Research Institute
2015-2018

City Of Hope National Medical Center
2015

Significance Protozoal proteasome is a validated target for antimalarial drug development, but species selectivity of reported inhibitors suboptimal. Here we identify with improved malaria β5 subunit over each active human proteasomes. These compounds kill the parasite in stage its life cycle. They interact synergistically β2 inhibitor and artemisinin. Resistance to arose through point mutation nonproteolytic β6 subunit. The same made mutant strain more sensitive less fit withstand...

10.1073/pnas.1806109115 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2018-07-02

Jumonji domain-containing protein 3 (JMJD3/KDM6B) demethylates lysine 27 on histone H3 (H3K27me3), a repressive epigenetic mark controlling chromatin organization and cellular senescence. To better understand the functional consequences of JMJD3 its expression was investigated in brain tumor cells. Querying patient profile databases confirmed overexpression high-grade glioma. Immunochemical staining two glioma cell lines, U251 U87, indicated intrinsic differences levels that were reflected...

10.1158/1541-7786.mcr-13-0268 article EN Molecular Cancer Research 2015-02-05

In a recent trial of intermittent preventive treatment in pregnancy (IPTp) Uganda, dihydroartemisinin-piperaquine (DP) was superior to sulfadoxine-pyrimethamine (SP) preventing maternal and placental malaria.We compared genotypes using sequencing, fluorescent microsphere, quantitative polymerase chain reaction assays at loci associated with drug resistance Plasmodium falciparum isolated from subjects receiving DP or SP.Considering aminoquinoline resistance, increased prevalences mutations...

10.1093/infdis/jix421 article EN The Journal of Infectious Diseases 2017-08-17

Dihydroartemisinin-piperaquine (DHA-PQ) is under study for intermittent preventive treatment during pregnancy (IPTp), but it may accelerate selection drug resistance. Understanding the relationships between piperaquine concentration, prevention of parasitemia, and decreased sensitivity can inform control policies optimization DHA-PQ dosing. Piperaquine concentrations, measures Plasmodium falciparum genotypes associated with aminoquinoline in Africa (pfmdr1 86Y, pfcrt 76T) were obtained from...

10.1128/aac.01393-18 article EN Antimicrobial Agents and Chemotherapy 2018-12-06

Tumor-tropic neural stem cells (NSCs) can be engineered to localize gene therapies invasive brain tumors. However, like other cell-based therapies, survival of therapeutic NSCs after transplantation is currently suboptimal. One approach prolonging cell transiently overexpress an antiapoptotic protein within the prior transplantation. Here, we investigate utility and safety this using a clinically tested, v - myc immortalized, human NSC line contain suicide gene, cytosine deaminase (CD-NSCs)....

10.1155/2018/7047496 article EN cc-by Stem Cells International 2018-06-20

Controlling malaria in high transmission areas, such as much of sub-Saharan Africa, will require concerted efforts to slow the spread drug resistance and impede transmission. Understanding fitness costs associated with development resistance, particularly within context transmission, can help guide policy decisions accomplish these goals, constraints might lead decreased drug-resistant strains. To determine if Plasmodium falciparum resistance–mediating polymorphisms impact on at different...

10.4269/ajtmh.17-0351 article EN American Journal of Tropical Medicine and Hygiene 2017-09-26

<p>Figure S2. (A) U251.JMJD3wt cells lack γH2AX foci. immunostained for foci (red) and counterstained with DAPI (blue). As a positive control formation, were irradiated (Cs137 source) 10 Gy γ-radiation examined after 24 hr. Note the absence of in untreated cells. Scale bar = µm. (B) Western blot U251.JMJD3 showing relative deficit non-irradiated cells.</p>

10.1158/1541-7786.22514577 preprint EN cc-by 2023-04-03

<div>Abstract<p>Jumonji domain-containing protein 3 (JMJD3/KDM6B) demethylates lysine 27 on histone H3 (H3K27me3), a repressive epigenetic mark controlling chromatin organization and cellular senescence. To better understand the functional consequences of JMJD3 its expression was investigated in brain tumor cells. Querying patient profile databases confirmed overexpression high-grade glioma. Immunochemical staining two glioma cell lines, U251 U87, indicated intrinsic differences...

10.1158/1541-7786.c.6540852 preprint EN 2023-04-03

<div>Abstract<p>Jumonji domain-containing protein 3 (JMJD3/KDM6B) demethylates lysine 27 on histone H3 (H3K27me3), a repressive epigenetic mark controlling chromatin organization and cellular senescence. To better understand the functional consequences of JMJD3 its expression was investigated in brain tumor cells. Querying patient profile databases confirmed overexpression high-grade glioma. Immunochemical staining two glioma cell lines, U251 U87, indicated intrinsic differences...

10.1158/1541-7786.c.6540852.v1 preprint EN 2023-04-03

<p>Figure S2. (A) U251.JMJD3wt cells lack γH2AX foci. immunostained for foci (red) and counterstained with DAPI (blue). As a positive control formation, were irradiated (Cs137 source) 10 Gy γ-radiation examined after 24 hr. Note the absence of in untreated cells. Scale bar = µm. (B) Western blot U251.JMJD3 showing relative deficit non-irradiated cells.</p>

10.1158/1541-7786.22514577.v1 preprint EN cc-by 2023-04-03
Coming Soon ...